Literature DB >> 20093346

Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease.

Kamyar Kalantar-Zadeh1, Lisa Gutekunst, Rajnish Mehrotra, Csaba P Kovesdy, Rachelle Bross, Christian S Shinaberger, Nazanin Noori, Raimund Hirschberg, Debbie Benner, Allen R Nissenson, Joel D Kopple.   

Abstract

In individuals with chronic kidney disease, high dietary phosphorus (P) burden may worsen hyperparathyroidism and renal osteodystrophy, promote vascular calcification and cardiovascular events, and increase mortality. In addition to the absolute amount of dietary P, its type (organic versus inorganic), source (animal versus plant derived), and ratio to dietary protein may be important. Organic P in such plant foods as seeds and legumes is less bioavailable because of limited gastrointestinal absorption of phytate-based P. Inorganic P is more readily absorbed by intestine, and its presence in processed, preserved, or enhanced foods or soft drinks that contain additives may be underreported and not distinguished from the less readily absorbed organic P in nutrient databases. Hence, P burden from food additives is disproportionately high relative to its dietary content as compared with natural sources that are derived from organic (animal and vegetable) food proteins. Observational and metabolic studies indicate nutritional and longevity benefits of higher protein intake in dialysis patients. This presents challenges to providing appropriate nutrition because protein and P intakes are closely correlated. During dietary counseling of patients with chronic kidney disease, the absolute dietary P content as well as the P-to-protein ratio in foods should be addressed. Foods with the least amount of inorganic P, low P-to-protein ratios, and adequate protein content that are consistent with acceptable palatability and enjoyment to the individual patient should be recommended along with appropriate prescription of P binders. Provision of in-center and monitored meals during hemodialysis treatment sessions in the dialysis clinic may facilitate the achievement of these goals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093346     DOI: 10.2215/CJN.06080809

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  109 in total

1.  Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives.

Authors:  Adamasco Cupisti; Omar Benini; Valerio Ferretti; Daniela Gianfaldoni; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2012-03-09       Impact factor: 3.655

2.  Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.

Authors:  Jessica E Miller; Csaba P Kovesdy; Keith C Norris; Rajnish Mehrotra; Allen R Nissenson; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2010-09-03       Impact factor: 3.754

3.  Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.

Authors:  Marc G Vervloet; Frans J van Ittersum; Rahel M Büttler; Annemieke C Heijboer; Marinus A Blankenstein; Piet M ter Wee
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

4.  Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study.

Authors:  Lynn M Taylor; Kamyar Kalantar-Zadeh; Theodore Markewich; Sara Colman; Debbie Benner; John J Sim; Csaba P Kovesdy
Journal:  J Ren Care       Date:  2011-03

Review 5.  Dietary restrictions in dialysis patients: is there anything left to eat?

Authors:  Kamyar Kalantar-Zadeh; Amanda R Tortorici; Joline L T Chen; Mohammad Kamgar; Wei-Ling Lau; Hamid Moradi; Connie M Rhee; Elani Streja; Csaba P Kovesdy
Journal:  Semin Dial       Date:  2015-02-03       Impact factor: 3.455

Review 6.  Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.

Authors:  Elizabeth R Stremke; Annabel Biruete; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

7.  Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective.

Authors:  Mario Cozzolino; Maria Antonietta Rizzo; Andrea Stucchi; Daniele Cusi; Maurizio Gallieni
Journal:  Ther Adv Chronic Dis       Date:  2012-03       Impact factor: 5.091

8.  Habitual dietary phosphorus intake and urinary excretion in chronic kidney disease patients: a 3-day observational study.

Authors:  L Salomo; A-L Kamper; G M Poulsen; S K Poulsen; A Astrup; M Rix
Journal:  Eur J Clin Nutr       Date:  2016-12-14       Impact factor: 4.016

Review 9.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

10.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.